Archives: ClinicianPOV

Optimizing the Sequence of Therapy for Follicular Lymphoma

This Q&A was edited for clarity and length. Disclosure Matthew J. Matasar, MD, reported affiliations with Merck & Co, Inc; Genentech, Inc; Roche Holding AG; GlaxoSmithKline, PLC; Bayer AG; Pharmacyclics LLC; Janssen Pharmaceuticals; Seagen Inc; ImmunoVaccine Technologies, Inc; Takeda Pharmaceutical Company, Ltd; Juno Therapeutics, Inc; Teva Pharmaceutical Industries, Ltd; Rocket Medical, LLC; Daiichi Sankyo Company,…